Qube Research & Technologies (QRT)
HBIO icon

Qube Research & Technologies (QRT)’s Harvard Bioscience HBIO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,703
Closed -$11.4K – 3773
2025
Q4 		$11.4K Sell
1,703
-2,023
-54% -$12K ﹤0.01% 3444
2025
Q3 		$16.3K Sell
3,726
-1,394
-27% -$6.61K ﹤0.01% 3306
2025
Q2 		$22.7K Buy
+5,120
New +$21.4K ﹤0.01% 3247
2024
Q3 		– Sell
-6
Closed -$160 – 3637
2024
Q2 		$160 Hold
6
– – ﹤0.01% 3412
2024
Q1 		$237 Hold
6
– – ﹤0.01% 4129
2023
Q4 		$342 Sell
6
-1,302
-100% -$58.8K ﹤0.01% 3946
2023
Q3 		$56.3K Buy
+1,308
New +$60.4K ﹤0.01% 2834
2022
Q4 		– Sell
-3,107
Closed -$80K – 2683
2022
Q3 		$80K Sell
3,107
-259
-8% -$8.57K ﹤0.01% 2032
2022
Q2 		$121K Buy
+3,366
New +$152K ﹤0.01% 1873

Other funds holding HBIO

WCM
Weber Capital Management San Francisco, California $118M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CCM
Corsair Capital Management New York $800M AUM 94.38% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $315M AUM 58.44% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Qube Research & Technologies (QRT)'s HBIO Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Harvard Bioscience (HBIO) in Q1 2026, closing a stake of 1,703 shares — an estimated $11.4K sold.

Qube Research & Technologies (QRT) first reported a position in HBIO in Q2 2022 and held it in 9 quarters. The position peaked at $121K in Q2 2022. 37 funds tracked by Wall St. Rank hold HBIO as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Harvard Bioscience position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,703 Harvard Bioscience shares in Q1 2026, an estimated $11.4K.
  • Qube Research & Technologies (QRT) first reported a position in Harvard Bioscience in Q2 2022 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s Harvard Bioscience position peaked at $121K in Q2 2022.
  • 37 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.